Transmission of hepatitis C virus by monoclonal-purified viral-attenuated factor VIII concentrate.
D016907:Adverse Drug Reaction Reporting Systems; D000911:Antibodies, Monoclonal; D002487:Centers for Disease Control and Prevention, U.S.; D002648:Child; D004340:Drug Contamination / Q000517:prevention & control; D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy; D016174:Hepacivirus; D006526:Hepatitis C / Q000635:transmission*; D018937:Hepatitis C Antibodies / Q000097:blood; D006358:Hot Temperature; D006801:Humans; D012449:Safety; D014481:United States; D014486:United States Food and Drug Administration; D014837:Voluntary Health Agencies
D000911:Antibodies, Monoclonal; D018937:Hepatitis C Antibodies; D005169:Factor VIII